Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Uncoupling between intravascular and distending pressures leads to underestimation of circulatory congestion in obesity

M. Obokata, YNV. Reddy, V. Melenovsky, H. Sorimachi, P. Jarolim, BA. Borlaug

. 2022 ; 24 (2) : 353-361. [pub] 20211121

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22019422
E-zdroje Online Plný text

NLK Medline Complete (EBSCOhost) od 2000-03-01 do Před 1 rokem
Wiley Free Content od 1999 do Před 1 rokem

AIMS: Patients with obesity frequently present with dyspnoea. Biomarkers that reflect wall stress are often used to evaluate circulatory congestion and help determine whether dyspnoea is of cardiac causes. Patients with obesity display greater external restraint on the heart, which may alter relationships between intravascular pressures and stress markers. METHODS AND RESULTS: Subjects with unexplained dyspnoea (n = 212) underwent cardiac catheterization with simultaneous echocardiography. Blood sampling was performed in a subset (n = 58). Relationships between echocardiographic and blood biomarkers of circulatory congestion and directly-measured haemodynamics were compared between participants with severe obesity [body mass index (BMI) ≥35 kg/m2 , Group B) and those without (BMI <35 kg/m2 , Group A). Circulatory congestion was assessed by pulmonary capillary wedge pressure (PCWP), and vascular distending pressure was assessed by left ventricular transmural pressure (LVTMP). As compared to Group A, participants in Group B displayed higher PCWP relative to N-terminal pro-B-type natriuretic peptide, mid-regional pro-atrial natriuretic peptide, troponin T, and growth differentiation factor-15 (all p < 0.01). In contrast, the relationships between LVTMP and the biomarkers were superimposable. Echocardiographic biomarkers revealed the same pattern: PCWP was higher for any E/e' ratio in Group B compared to Group A, but the relationship between LVTMP and E/e' was similar. In contrast, levels of C-terminal pro-endothelin-1 and mid-regional pro-adrenomedullin were more robustly correlated with PCWP (r = 0.67 and r = 0.62, both p < 0.0001), with no differential relationship based upon BMI. CONCLUSIONS: Non-invasive haemodynamic markers underestimate circulatory congestion in patients with obesity, an effect that appears related to uncoupling between cardiac wall stress and intravascular pressures. This may lead to systematic under-recognition of congestion in patients with obesity.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22019422
003      
CZ-PrNML
005      
20220804135636.0
007      
ta
008      
220720s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ejhf.2377 $2 doi
035    __
$a (PubMed)34755429
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Obokata, Masaru $u Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA $u Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan
245    10
$a Uncoupling between intravascular and distending pressures leads to underestimation of circulatory congestion in obesity / $c M. Obokata, YNV. Reddy, V. Melenovsky, H. Sorimachi, P. Jarolim, BA. Borlaug
520    9_
$a AIMS: Patients with obesity frequently present with dyspnoea. Biomarkers that reflect wall stress are often used to evaluate circulatory congestion and help determine whether dyspnoea is of cardiac causes. Patients with obesity display greater external restraint on the heart, which may alter relationships between intravascular pressures and stress markers. METHODS AND RESULTS: Subjects with unexplained dyspnoea (n = 212) underwent cardiac catheterization with simultaneous echocardiography. Blood sampling was performed in a subset (n = 58). Relationships between echocardiographic and blood biomarkers of circulatory congestion and directly-measured haemodynamics were compared between participants with severe obesity [body mass index (BMI) ≥35 kg/m2 , Group B) and those without (BMI <35 kg/m2 , Group A). Circulatory congestion was assessed by pulmonary capillary wedge pressure (PCWP), and vascular distending pressure was assessed by left ventricular transmural pressure (LVTMP). As compared to Group A, participants in Group B displayed higher PCWP relative to N-terminal pro-B-type natriuretic peptide, mid-regional pro-atrial natriuretic peptide, troponin T, and growth differentiation factor-15 (all p < 0.01). In contrast, the relationships between LVTMP and the biomarkers were superimposable. Echocardiographic biomarkers revealed the same pattern: PCWP was higher for any E/e' ratio in Group B compared to Group A, but the relationship between LVTMP and E/e' was similar. In contrast, levels of C-terminal pro-endothelin-1 and mid-regional pro-adrenomedullin were more robustly correlated with PCWP (r = 0.67 and r = 0.62, both p < 0.0001), with no differential relationship based upon BMI. CONCLUSIONS: Non-invasive haemodynamic markers underestimate circulatory congestion in patients with obesity, an effect that appears related to uncoupling between cardiac wall stress and intravascular pressures. This may lead to systematic under-recognition of congestion in patients with obesity.
650    _2
$a echokardiografie $7 D004452
650    12
$a srdeční selhání $x diagnóza $x etiologie $7 D006333
650    _2
$a hemodynamika $7 D006439
650    _2
$a lidé $7 D006801
650    _2
$a obezita $x komplikace $7 D009765
650    _2
$a plicní tlak v zaklínění $7 D011669
650    _2
$a tepový objem $7 D013318
650    _2
$a funkce levé komory srdeční $7 D016277
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Reddy, Yogesh N V $u Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA
700    1_
$a Melenovsky, Vojtech $u Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA $u Institute for Clinical and Experimental Medicine-IKEM, Prague, Czech Republic
700    1_
$a Sorimachi, Hidemi $u Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA
700    1_
$a Jarolim, Petr $u Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
700    1_
$a Borlaug, Barry A $u Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA $1 https://orcid.org/0000000193750596
773    0_
$w MED00006634 $t European journal of heart failure $x 1879-0844 $g Roč. 24, č. 2 (2022), s. 353-361
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34755429 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135630 $b ABA008
999    __
$a ok $b bmc $g 1822847 $s 1170665
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 24 $c 2 $d 353-361 $e 20211121 $i 1879-0844 $m European journal of heart failure $n Eur J Heart Fail $x MED00006634
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...